Group structure and shareholders
Corporate structure as of December 31, 2025
Scope of consolidation / Operating business units
Bellevue Group AG is the only listed company within the Group. The investment companies we manage, BB Biotech AG and Bellevue Healthcare Trust plc, are independent companies listed on their respective stock exchanges. The companies consolidated by Bellevue Group are listed, together with information regarding their domicile and share capital and the interest held by the Group, in note 6 «Major subsidiaries» to the consolidated financial statements. As of December 31, 2025, the Bellevue Asset Management operating business unit represents the Group's only reportable segment. Further information on the operating business units is provided in note 1 «Segment information» to the consolidated financial statements.
Major shareholders
Based on the notifications received and published by Bellevue Group AG, the following parties hold significant voting rights:
Shareholder or beneficial owner | 31.12.2025 Voting rights held | 31.12.2025 Number of shares held | 31.12.2024 Voting rights held | 31.12.2024 Number of shares held | ||||
Martin Bisang, Küsnacht | 23.91% | 3 218 400 | 23.91% | 3 218 400 | ||||
Hansjörg Wyss, Cambridge MA (USA) | 9.66% | 1 300 000 | 9.66% | 1 300 000 | ||||
Jürg und Manuela Schäppi, Rapperswil-Jona | 9.18% | 1 235 299 | 9.18% | 1 235 299 |
Disclosure notifications are retrievable from the SIX Swiss Exchange website at: https://www.ser-ag.com/en/resources/notifications-market-participants/significant-shareholders.html#/
Cross-shareholdings
There are no cross-shareholdings between Bellevue Group AG or its subsidiaries and other corporations.